Recs

0

Foolish Review: Vertex Earnings

By | More Articles
January 30, 2013 | Comments (0)

In the following video, Motley Fool health-care analyst David Williamson takes a look back at Vertex's (NASDAQ: VRTX  ) earnings report this quarter. While it was far from a good quarter for the company, things were somewhat better than expected, leading to a sell-off that wasn't nearly as bad as analysts had feared. David tells us why the company struggled this quarter, and what investors can expect from them in the months to come.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report, "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

David Williamson has no position in any stocks mentioned. The Motley Fool recommends Gilead Sciences, Johnson & Johnson, and Vertex Pharmaceuticals. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 2225583, ~/Articles/ArticleHandler.aspx, 5/22/2013 5:35:47 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 8 hours ago Sponsored by:
DOW 15,387.58 52.30 0.34%
S&P 500 1,669.16 2.87 0.17%
NASD 3,502.12 5.69 0.16%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/21/2013 4:00 PM
VRTX $79.47 Up +2.09 +2.70%
Vertex Pharmaceuti… CAPS Rating: ***
JNJ $88.59 Up +0.58 +0.66%
Johnson & Johnson CAPS Rating: *****
GSK $52.65 Up +0.44 +0.84%
GlaxoSmithKline CAPS Rating: ****
GILD $56.47 Up +0.73 +1.31%
Gilead Sciences CAPS Rating: ****

Advertisement